Endocrinology, Diabetes & Metabolism — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Also called: endo. Subspecialty fellowship of Internal Medicine, reached through an IM residency and then a 2-year fellowship rather than matched from medical school. Organ system: the endocrine axes of thyroid, pituitary, adrenal, gonads, pancreas and metabolism, and bone and mineral. The specialty of hormones and the feedback loops that regulate the whole body.

The 30-second version

Endocrinology is the cerebral, hormone-logic corner of internal medicine, the field organized around the body's chemical control systems: diabetes and metabolism, thyroid, pituitary, adrenal, reproductive hormones, and bone. It is predominantly outpatient, cognitive rather than procedural, and built on long-term relationships: you reason to a root cause, coach behavior change over years, and titrate therapy rather than operate. It is also one of the most controllable, lifestyle-friendly careers in medicine: mostly clinic-based, low call, telehealth-friendly, a career you can genuinely still be doing at 65.

And it carries one of medicine's most honest paradoxes: you do two extra years of fellowship after a full IM residency to earn, on average, around or below what a general internist makes without subspecializing. Endocrinologists know this, and choose the field anyway, for the physiology and the life rather than the money. That trade is the whole personality of the field: deep intellectual engagement and a humane schedule in exchange for near-bottom-of-medicine pay.

Quick dashboard (details and sources below)
How you get here Through Internal Medicine — not a direct match from med school
Training after med school IM residency (3) + Endocrinology fellowship (2) = 5 yrs after med school
Total from college start ~13 years (4 undergrad + 4 med school + 3 IM residency + 2 fellowship)
Competitiveness (as an IM fellowship) Low — one of the less competitive IM subspecialties for US MDs ⟳
Typical full-time pay ~$265,000–$290,000 total comp — near the bottom of medicine ⟳
Pay range (structure) Full spectrum ~$175k–$350k; FastRVU planning estimate ~$245k · Doximity median ~$291k ⟳
Lifestyle Outpatient, ~4–4.5 days/week, low call, no OR, telehealth-friendly
Burnout Middle-to-low for medicine (~low-30s to ~44%) ⟳
% women ~44% practicing; ~70% of fellows — one of the most female-predominant IM subspecialties ⟳
DO / IMG accessibility Very open (~16% DO, ~55% IMG of the incoming fellowship class) ⟳

What they actually do

Endocrinologists diagnose and manage disorders of the body's hormone systems: diabetes and metabolic disease, thyroid disorders and thyroid cancer, pituitary and adrenal disease, calcium/bone and parathyroid disorders, reproductive and gonadal hormones (PCOS, hypogonadism, menopause), and gender-affirming care. The core skill is diagnostic reasoning about regulated systems: interpreting how a feedback loop (the HPA, HPT, or HPG axis) has broken, ordering and reading the right dynamic hormone tests, and adjusting therapy to restore balance. Much of the value is in the thinking.

The work is longitudinal and clinic-based. In diabetes especially, you follow the same patients for years, reviewing labs and continuous-glucose-monitor (CGM) data, titrating insulin and GLP-1 medications, and coaching diet, exercise, and adherence over the long arc of a chronic disease. A large part of the job is education and motivation. Inpatient consult call exists (managing a hospitalized patient's blood sugar, sodium, or calcium) but is low-intensity and non-procedural: there is no ward to run, no overnight airway, no bleeding artery.

Representative procedures (limited, since this is a mostly non-procedural field): thyroid ultrasound and fine-needle aspiration (FNA) biopsy · continuous-glucose-monitor and insulin-pump management/titration · bone densitometry (DXA) interpretation · dynamic endocrine testing (stimulation/suppression). Compared with a procedural IM subspecialty like cardiology or GI, the hands-on menu is short, and that limited procedural revenue is a direct driver of the pay paradox below.

A day in the life: Mostly a full outpatient clinic, a run of scheduled 20–40 minute visits, often 20–25 patients across the day, heavy on diabetes follow-ups plus thyroid nodules, osteoporosis, PCOS, and adrenal/pituitary workups. Between patients you're doing dense chart review of labs and CGM downloads, and fighting a real load of prior authorizations and insurance denials for expensive medications (insulins, GLP-1s). Little to no evening or weekend work; when there is inpatient consult service, you're advising, not rushing to a procedure. You typically go home at a predictable hour with no procedural emergencies waiting.

The training path & time to completion

This is a two-step entry, and that structure matters. You cannot choose endocrinology out of medical school. You first commit to Internal Medicine, complete the full residency, and then apply to endocrinology through a separate fall fellowship match.1

MD or DO (4 yrs) → Internal Medicine residency (3 yrs) → Endocrinology, Diabetes & Metabolism fellowship (2 yrs) → board-eligible with ABIM in the subspecialty.1

  • Fellowship length: 2 years for the standard clinical track and board eligibility. Research-intensive positions add a 3rd year, though trainee interest in those fell from ~23% (2015) to ~15% (2019).12
  • Board: the American Board of Internal Medicine (ABIM), Endocrinology, Diabetes and Metabolism, and note the prerequisite: you must first be ABIM-certified in Internal Medicine. The subspecialty board sits on top of the IM board.1
  • Two-step entry note: Because you enter through IM, endocrinology's competitiveness is measured at the fellowship stage (the fall Medicine Subspecialty Match, below), not at the med-school Match. The upside of the longer path: at the end of IM residency you are already a board-eligible internist who could practice general IM or hospitalist medicine, so the fellowship is a genuine choice to specialize further (and, as the compensation section shows, often a choice to earn less).
  • Total from med school: 5 years (3 + 2). Total from the start of college: ~13 years (4 undergrad + 4 med school + 3 IM + 2 fellowship).

How competitive is it?

Endocrinology is reached through the NRMP Specialties Matching Service, the Medicine and Pediatric Specialties Match held each fall (the "Medicine Subspecialty Fall Match"), for fellowships starting the following July.3 Its competitiveness has a genuine nuance.

Headline: it fills almost completely, yet is one of the least competitive IM subspecialties for US MD applicants. Both things are true at once.

For the 2026 appointment year (most recent complete data):3

  • 165 programs · 398 positions offered · 389 filled → 97.7% fill rate (7 unfilled programs). ⟳
  • ~1.2 active applicants per position — 484 applicants for 398 seats. Close to parity. Contrast that with cardiology (1.6), GI (1.6) and pulmonary/critical care (1.5), where applicants outnumber positions by half again. ⟳
  • Cross-check: fill rate was 98.4% in the 2025 appointment year, described as "among the specialties with high fill rates."4 ⟳

Here's the nuance that makes it accessible despite the high fill rate: US MD graduates fill only ~26% of endocrinology positions, far below cardiology (~51%) or GI (~56%).3 The seats fill to ~98% largely because international medical graduates take the majority of them (see demographics). So for a solid US MD or DO internist who wants the field, endocrinology is one of the more attainable fellowships in medicine.

The longer trend reinforces this: positions grew ~50% (223 in 2009 → 326 in 2019) while the applicant-to-position ratio drifted toward ~1.0. Endocrinology, nephrology, and infectious disease are the IM subspecialties that have lost competitiveness since 2009.2 ⟳

The honest read: endocrinology sits near the bottom of the IM-subspecialty competitiveness ladder (alongside geriatrics, nephrology, infectious disease). That accessibility is a real feature for applicants who want the work and the lifestyle without a brutal, research-gated match, but it's also a market signal that's inseparable from the pay story below.

Compensation — the robust version

Name it squarely: endocrinology is consistently one of the lowest-paid specialties in all of medicine, and it frequently pays less than general internal medicine, despite the two extra years of fellowship. This is real and well-documented, not a rounding artifact. It is the single most important fact a premed should carry away from this profile.

The paradox, in sources' own words. Doximity 2025 puts endocrinology at $290,606 and general internal medicine at $326,116, so endocrinologists earn less on average than the general internists who did not subspecialize.56 The ranking needs care, because the two surveys disagree about how low it sits. On Medscape 2026 it is 26th of 29 at $284,000, tied with rheumatology, with infectious diseases ($282,000), public health ($277,000) and pediatrics ($266,000) below it. On Doximity 2025 it sits above general pediatrics and every pediatric subspecialty. One of the lowest-paid specialties, yes. The third-lowest in all of medicine, no — a secondary ranking this page used to quote said that, and the site's own pediatrics profile contradicts it.5 MedMoneyGuide (2026) calls it "the internal medicine fellowship with the weakest financial ROI," pegging the compensation delta versus general IM at −$20,000 to +$30,000, or roughly break-even to negative, while general IM runs $292,000–$345,000 and hospitalist medicine $290,000–$380,000 (with a $30k–$60k nocturnist premium). A hospitalist with zero fellowship routinely out-earns a fellowship-trained endocrinologist.7 ⟳

Why this happens. Endocrinology is a predominantly cognitive / E&M (evaluation & management)-based specialty. Revenue comes from office visits and chronic-disease management, not high-RVU procedures or hospital volume. In fee-for-service medicine, "thinking" reimburses far less than "doing," and endocrinology's short procedural menu (§ What they actually do) means there's little high-margin work to bill.7

National number. Four estimates span ~$245K to ~$291K depending on survey and definition (base against total comp), and the order matters more than the midpoint:5869

  • Doximity 2025: $290,606 total comp (the upper anchor).56
  • FastRVU (2026): a $245,000 median compensation estimate, the conservative employed-end anchor. The same source separately publishes a 5,700 wRVU/yr median and a ~$55/wRVU contract modeling rate, and those two are planning references rather than the derivation of the salary: multiplied together they give $313,500, which is a different number from the median beside them.9
  • Medscape 2024: ~$256,000 (base), a ~4% drop from 2023's ~$267,000.8
  • BLS doesn't break out endocrinology; it's folded into General Internal Medicine Physicians, mean $267,200 (May 2025), and endocrinologists typically sit at or below that internist mean, which is the paradox in one line.810

A defensible "typical full-time" figure for 2025–26 is ~$265K–$290K total compensation.89 ⟳

The spread (structure). Full salary spectrum runs $175,000–$350,000 (market midpoint ~$275,000).11 Productivity percentiles (FastRVU 2026 wRVU benchmark references): 25th pct 4,500 · median 5,700 · 75th pct 7,100 · 90th pct 8,700 wRVU. Top-decile producers clear the median comfortably, and they get there through panel size and visit throughput rather than through procedures. Those counts do not convert into salaries at ~$55: 8,700 wRVU would imply $478,500, well past the $350,000 top of the salary spectrum in the sentence before it.9 Median incentive bonus ~$37,500, with ~three-quarters of endocrinologists having some bonus access.812 ⟳

Seniority barely moves the needle, and the curve is flat. Experience-based figures (Medscape via Physicians Thrive): entry-level ~$190k · 1–4 yrs ~$202k · ~10 yrs ~$226k · 20+ yrs ~$234k, a ~$44k spread from start to late career, far flatter than procedural fields.8 ⟳

Geography.

  • Highest-paying states: New York $307,036 · Vermont $302,341 · Pennsylvania $281,177 · Washington $276,279 · New Hampshire $274,574.8 ⟳
  • Lowest-paying states: Arkansas $205,468 · Florida $206,622 · Michigan $216,113 · Kentucky $216,365 · West Virginia $217,158.8 ⟳

Urban vs. rural, and the familiar quirk: smaller markets pay more. PhysEmp (2026) notes "the largest markets by opportunity count offer average-to-below-average compensation, while smaller markets show stronger pay." Rural and underserved markets pay a premium, especially for locums, and high-demand shortage areas (South, Midwest, rural) compete with signing bonuses and loan repayment. Endocrinology's heavily outpatient nature means it can be practiced in smaller communities, though many rural areas have zero endocrinologists at all.1112 ⟳

Academic vs. private. No endocrinology-specific split was published in the surveys reviewed. Across all specialties, Doximity 2025 pegs academic settings ($382k) and government ($303k) below private single-specialty groups (~$477k); for endocrinology specifically, academic roles typically pay below the ~$245K–$290K median given research/teaching time. (Directional; endo-specific academic dollars not separately published, so verify.)6 ⟳

How income actually gets levered up. Because base comp is low and procedures are few, the real upside knobs are:1213

  • Obesity / weight-management medicine. The biggest lever. GLP-1-driven demand supports cash-pay weight-loss clinics, concierge/membership models, and telehealth.
  • Locum tenens. $150–$200/hr; a full-time locum schedule (~20 days/mo at $185/hr) can reach ~$355,200/yr, and a hybrid employed + locum model ~$361,000, notably above the employed median, reflecting rural/shortage premiums.
  • Industry / pharma. Advisory, trials, and medical-affairs roles ride the enormous diabetes/obesity drug pipeline; ~40% of physicians do some outside paid work.
  • Diabetes-tech throughput. CGM and pump-management billing, recurring titration visits.

The trend that colors all of it. Endocrinology comp rose ~4% in the latest Medscape cycle, slightly ahead of the ~3% broader physician average, and demand is enormous and rising (see below).1314 But comp stays near the bottom of medicine not because demand is soft, but because current fee-for-service payment structurally underweights cognitive work. The demand-pay disconnect is the defining feature of this market. ⟳

Lifestyle & the outpatient bargain

The single most-cited pro of endocrinology: it's one of the most controllable, humane schedules in medicine. It is genuinely outpatient-dominant, and most endocrinologists build predictable clinic weeks of roughly 4 to 4.5 days, with little to no evening or weekend work. Inpatient consult call exists but is low-intensity and non-procedural. There's no ward-running, no overnight airway, no OR emergency. Schedule control is high: because the work is cognitive and clinic-based, endocrinologists have unusual latitude over how they build their week, and it's one of the most part-time-friendly and telehealth-friendly fields in all of medicine, because diabetes, thyroid follow-up, and hormone titration translate beautifully to video visits and remote data review.1516

The honest catch on "easy hours": the lifestyle is real, but the pace inside clinic can grind. High patient volumes (often 20–25/day), dense chart and CGM-data review, and a heavy load of prior authorizations and insurance battles for expensive medications make for a different flavor of exhaustion, bureaucratic and cognitive rather than physically brutal.1115

Lifestyle rating: 4/5. High schedule control, low call, no procedures or overnights; docked mainly for clinic volume and administrative friction rather than hours.

Wellbeing — the part to take seriously

Burnout: middle-to-low for medicine. The data are genuinely mixed, and they read as nuance rather than a headline. Medscape 2024 place endocrinology among the lowest-burnout specialties at ~44%; other Medscape cycles have put it lower, in the low-to-high 30s (~31% in one report, ~38% in another).1617 The named drivers are consistent: bureaucratic tasks (~69%), insufficient compensation (~51%), and administrative load, rather than raw hours.16 ⟳

The signature wellbeing paradox: content but underpaid. This is the defining wellbeing feature of the field, and the mirror image of the compensation section. Endocrinologists report high life satisfaction alongside low "feel fairly paid" numbers: only about 45% feel fairly compensated, and one survey found ~41% would willingly take a pay cut to protect work-life balance. This page used to pair that with a figure of roughly 85% who would choose endocrinology again. Nobody has published a would-choose-again rate by specialty since about 2019, so there is no figure to give here and none is asserted. The people in this field have largely made peace with the money and like their lives.18 ⟳

Career longevity is excellent, and a real selling point. Low physical intensity, no high-acuity call, a teachable and remote-able workflow, and strong intellectual engagement make endocrinology a career you can practice deep into your 60s and scale down gradually (part-time, telehealth) rather than burn out and quit. It's a classic "still doing it at 65" field, a stark contrast to the acute-care specialties with young attrition profiles.15

Who's in the field (demographics)

  • Women: ~44% of practicing endocrinologists, but ~70% of current fellows and trainees (2024–25 GME Census), making endocrinology one of the most female-predominant IM subspecialties, and a field projected to become increasingly female as the pipeline replaces an older, more male workforce.1920 ⟳
  • IMG: ~55% of the incoming fellowship class (2026) is international medical graduates: U.S.-citizen IMGs ~19% plus non-U.S. IMGs ~36%. Endocrinology is explicitly among the subspecialties with the highest IMG share; IMGs have been the largest group of first-year fellows since ~2013.321 ⟳
  • DO: ~16% of the incoming class (2026), a genuinely open field for osteopathic graduates.3 ⟳
  • URiM: the trainee counts are published and the practicing ones are not. ACGME's Data Resource Book AY2024-25, Table C.23, gives active residents and fellows by specialty and race, endocrinology included, as head counts rather than percentages — and it covers everyone in ACGME training, so it does not drop DOs and IMGs the way AAMC's resident data does. For practicing endocrinologists there is no current table; the last citable one is AAMC's Diversity in Medicine (2019). An et al. studied DEI in endocrinology fellowships (Endocrine Practice, 2023), and that paper is where a fellowship-level enrollment percentage would appear.22 ⟳

Culture, personality & the online stereotypes

Who gravitates here: physiology and hormone-logic lovers, the people who loved the endocrine unit of physiology, the elegance of a system regulating itself through feedback loops and axes.15 Cerebral puzzle-solvers and diagnosticians who'd rather reason to a root cause than do a procedure. Longitudinal relationship-builders who want to follow patients (especially in diabetes) for years, coaching behavior change. Patient teachers, since so much of the job is education and motivation. And, openly, lifestyle-over-income optimizers, since nearly everyone in the field acknowledges choosing balance over maximum earnings, and many "practice what they preach" on nutrition and exercise. As always, plenty of people in the field do not fit any single mold.

The stereotypes. Community caricatures rather than facts, each with an unfair edge:

  • "The smartest but worst-paid IM subspecialty. Why do a fellowship to earn less?" There's a kernel of truth (the pay paradox is real), but "smartest" is a backhanded compliment and "why bother" unfairly reduces a rich, high-demand, high-satisfaction field to a spreadsheet, erasing the people genuinely happiest with their daily work.
  • "It's all diabetes management." Diabetes and obesity are a large slice of volume, but the field spans thyroid cancer, pituitary and adrenal disease, calcium/bone metabolism, reproductive disorders, and gender-affirming care. The caricature undersells the intellectual range.
  • "Lifestyle-friendly and cerebral." Mostly fair, and the one stereotype endocrinologists tend to embrace. The unfair edge is using "lifestyle specialty" dismissively to mean "not serious," ignoring the cognitive difficulty and the real clinic grind.

What people say online (synthesized and paraphrased, not quotes): Across trainee and physician forums the picture is remarkably consistent. The dominant recurring theme is the "fellowship for a pay cut" paradox, and trainees openly debate why anyone would spend two extra years to earn around or below a general internist or hospitalist, and the consensus answer is blunt: do it because you love the physiology and want the lifestyle, not for ROI. There's widespread agreement that the lifestyle is a real, tangible win (predictable hours, minimal call, no procedures, strong telehealth fit, easy to go part-time). The most consistent gripe is administrative burden: prior auths for insulin and GLP-1s, denials, and feeling "devalued" by reimbursement cuts, described as the main daily drain, more than hours. A recurring caution is that geography drives everything (better pay and demand in suburban/rural areas; saturated, lower-paying coastal metros and academic hubs). And underneath it all runs a steady note of contentment: people who did it rarely regret it, and often push back on the "don't do it, it pays badly" advice by pointing to their quality of life.

Voices from the field. Paraphrased from public writing, with links to the originals:

  • An endocrinologist writing for KevinMD argues endocrinologists are needed more than ever yet are actively devalued, citing CMS reimbursement cuts (thyroid ultrasound/biopsy fees, consult codes), a crushing prior-auth burden, and unpaid patient-education time push graduates away from a field facing a worsening shortage; cutting physician reimbursement, she argues, is shortsighted when demand is exploding.23
  • Medscape's endocrinology lifestyle reporting documents the wellbeing paradox: endocrinologists rank at or near the top for happiness outside work while carrying middling burnout, with bureaucracy rather than hours as the leading cause, and ~41% saying they'd trade salary for balance.18
  • Endocrine Society workforce analyses frame the field around a structural supply-demand mismatch: a small, aging workforce against a diabetes and obesity tidal wave.24

Why people choose it / why people leave

Why choose it: you love endocrine physiology and diagnostic reasoning more than procedures · a controllable, largely 9-to-5, low-call, no-weekend lifestyle within IM · continuity and long-term relationships, especially in diabetes · strong telehealth flexibility and easy part-time/scale-down options · durable job security in a field with a large, worsening shortage · a comparatively attainable fellowship to match into.

Why leave or avoid it: you're optimizing for income, since this is near the bottom of subspecialty pay, sometimes below general IM, after two extra years · you want procedures, acuity, or variety-by-adrenaline · you'd be ground down by prior auths, denials, and long-arc non-adherence · you'd resent watching co-residents who did no fellowship out-earn you.

Best fit if: you geeked out over feedback loops and axes in physiology · you're patient, pedagogical, and energized by long-arc behavior change · you explicitly rank lifestyle and intellectual satisfaction above maximum earnings.

Not for you if: you measure career success primarily in dollars or RVUs · you need the dopamine of procedures or acute rescues · you have low tolerance for administrative friction and slow, incremental progress.

The FLI angle — Endocrinology for first-gen, low-income & immigrant students

Endocrinology is an unusually strong-fit-but-honest-tradeoff specialty for FLI students, and the tradeoff has to be named squarely.

Where endocrinology fits FLI realities well:

  • An accessible fellowship. Endocrinology is among the least competitive IM subspecialties to match into. An FLI student without elite research pedigree or connections can realistically reach it, a meaningful equity point, since the most lucrative fellowships (cardiology, GI) are the most connection- and research-gated. The most attainable good-lifestyle path in IM is not the same as the least valuable one.
  • A controllable, sustainable lifestyle. Predictable hours and low call protect against burnout and make the career compatible with the caregiving responsibilities FLI students disproportionately carry (supporting parents, siblings, or young families).
  • Telehealth flexibility. The field's remote-friendliness opens geographic and scheduling options: you can serve underserved and rural communities (often the ones FLI students come from) without necessarily relocating there full-time.
  • Enormous shortage and demand. Job security is excellent, especially in the suburban, rural, and underserved areas with the highest diabetes burden, and loan-forgiveness programs (PSLF, NHSC, state loan repayment for underserved areas) map well onto exactly where endocrinologists are most needed.

The honest catch, named squarely:

  • Endocrinology can pay less than general internal medicine, and you do two extra years of fellowship (two years of lost attending income plus a fellow's stipend) to get there. For a student carrying heavy loans and possibly supporting family, that is a real, quantifiable cost, and the lifetime gap versus higher-paying paths can run into the low millions over a career.
  • The math still works, because endocrinology pays a solid upper-middle physician income (~$265K–$290K), life-changing money for most FLI backgrounds. But the guidance has to be blunt: choose endocrinology for the work and the life, not the money. If maximizing income to lift your family out of financial precarity is the primary goal, general IM (especially hospitalist medicine) or a higher-paying subspecialty gets you there faster with less training. If you love the physiology and value the lifestyle, endocrinology is one of the most humane, sustainable, and mission-aligned careers in medicine, and its shortage means your work matters enormously.

Bottom line: endocrinology is one of the most attainable routes to a genuinely good-lifestyle, high-security physician career: accessible to match, controllable to live, telehealth-friendly, and desperately needed. But it comes bundled with the field's defining honesty: two extra years of training for pay that sits at or below the general internist you already were. Go in with eyes open, and choose it for the work.

Sub-subspecialties & focus areas

Endocrinology is more varied than the "just diabetes" stereotype suggests. Common focus areas within the field:25

  • Diabetes & obesity medicine. The largest slice by volume and the field's center of gravity, now supercharged by the GLP-1 era; the most telehealth-adaptable and highest-demand niche, and the clearest cash-pay upside lever.
  • Thyroid & endocrine oncology. Thyroid nodules, thyroid cancer, and neuroendocrine tumors; the most procedural corner (thyroid ultrasound and fine-needle biopsy).
  • Reproductive & pituitary / neuroendocrine. Hypogonadism, menopause, PCOS, and hypothalamic-pituitary and adrenal disorders. (Note: reproductive endocrinology & infertility, REI, is a separate OB/GYN fellowship path rather than this IM fellowship, and it pays notably more.)
  • Bone & mineral / metabolic. Osteoporosis, calcium and parathyroid disorders, metabolic bone disease; a growth area with the aging population.
  • Gender-affirming / transgender care. A fast-growing subspecialization within endocrinology.
  • Pediatric endocrinology. A distinct pediatrics fellowship (Type 1 diabetes, growth, puberty, congenital disorders), notably even lower-paid than adult endocrinology, the pay paradox in its most extreme form.

The demand story (why the field matters)

The compensation paradox persists despite soaring demand rather than because of it:

  • Roughly 8,000 practicing endocrinologists in the US, a large share near retirement, against 37M+ Americans with diabetes and ~96M with prediabetes; only ~300–342 new endocrinologists finish training per year.2526
  • A baseline shortage of ~1,500 adult FTE endocrinologists, projected to widen to ~2,700 adult FTEs, driven primarily by rising diabetes prevalence.27
  • The GLP-1 / obesity boom has thrust the once-"quiet" specialty into the cultural spotlight: about one in eight US adults say they have ever taken a GLP-1 and 6% are currently taking one (KFF, May 2024), obesity GLP-1 prescriptions surged 587% (2019–2024), and the global GLP-1 market is projected toward $200 billion by 2030.1428 ⟳

Fun facts

  • Endocrinology is one of the few fields where physicians report they'd take a pay cut for balance, because many effectively already have.18
  • Only about 45% of endocrinologists say they feel fairly paid, one of the lowest figures in medicine.18
  • There are only roughly 8,000 practicing endocrinologists in the US against 37M+ Americans with diabetes, a structural mismatch that defines the field.2526
  • The GLP-1 (semaglutide/tirzepatide) era turned obesity medicine into one of the hottest areas in all of medicine, centered on this formerly "quiet" specialty.14
  • It's one of the least competitive IM fellowships to match into, and accessibility is a genuine feature for applicants who want the life without a brutal match.23
  • Endocrinology has ranked among the top specialties for out-of-work happiness in Medscape surveys, a lifestyle dividend that never shows up in the salary tables.18

Sources

Footnotes

  1. Training path, 2-year fellowship, and board requirements (ABIM Endocrinology, Diabetes & Metabolism; prior ABIM Internal Medicine certification required). ABIM — Endocrinology, Diabetes & Metabolism policies (2026) (https://www.abim.org/certification/policies/internal-medicine-subspecialty-policies/endocrinology-diabetes-metabolism/); FREIDA/AMA specialty profile (2024) (https://freida.ama-assn.org/specialty/endocrinology-diabetes-and-metabolism-im). ↩ ↩2 ↩3 ↩4

  2. Endocrinology fellowship recruitment trends, declining competitiveness since 2009, 3-year research-track interest. JCEM, "Trends in the Endocrinology Fellowship Recruitment" (2020) (https://academic.oup.com/jcem/article/105/6/1701/5809736). ↩ ↩2 ↩3

  3. NRMP, Results and Data: 2026 Specialties Matching Service (2026) — 165 programs, 398 positions, 389 filled (97.7%), 484 active applicants (~1.2 applicants per position), US MD 26.4%, DO 16.3%, US-citizen IMG 19.1%, non-US IMG 35.9%. Correction, 2026-08-13: this footnote and the body bullet both read "~1.2 positions per active applicant", which inverts the ratio and tells a reader there are more seats than candidates when the reverse is true. https://www.nrmp.org/wp-content/uploads/2026/05/SMS_Results_and_Data_2026_Revised-20260522.pdf ; press release: https://www.nrmp.org/about/news/2026/02/nrmp-publishes-results-and-data-for-the-2026-specialties-matching-service/ ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  4. 2025 appointment-year fill rate 98.4%; "among specialties with high fill rates." AMA, "Considering fellowship? Check in on the latest applicant trends" (2025 AY) (https://www.ama-assn.org/medical-residents/medical-fellowships/considering-fellowship-check-latest-applicant-trends). ↩

  5. Endocrinology $290,606 and general internal medicine $326,116 — Doximity, 2025 Physician Compensation Report (2024 earnings), read directly at https://www.doximity.com/reports/physician-compensation-report/2025. Cross-specialty position from Medscape Physician Compensation Report 2026 (2025 earnings): diabetes and endocrinology $284,000, 26th of 29, tied with rheumatology, above infectious diseases $282,000, public health and preventive medicine $277,000, and pediatrics $266,000. Correction, 2026-08-13: this page previously called endocrinology "the #3 lowest-paid specialty in all of medicine," sourced to a secondary ranking of Doximity's data on a med-school admissions-consulting site, which this repo bans as a citation host. It is not supported by either survey read directly, and it contradicts this site's own pediatrics profile, which places general pediatrics below endocrinology on both. ↩ ↩2 ↩3 ↩4

  6. Doximity 2025 Physician Compensation Report — endo median $290,606; cross-specialty academic/government/private benchmarks. https://www.doximity.com/reports/physician-compensation-report/2025 ; summary via Contract Diagnostics (https://contractdiagnostics.com/blog/2025-doximity-physician-compensation-report-know-your-worth/). ↩ ↩2 ↩3 ↩4

  7. Endocrinology as weakest-ROI IM fellowship; comp delta vs general IM −$20k to +$30k; general IM $292k–$345k, hospitalist $290k–$380k; cognitive/E&M reimbursement explanation. MedMoneyGuide, "Internal Medicine Salary" (2026) (https://medmoneyguide.com/guides/internal-medicine-salary). Corrected 2026-08-17: these figures stay with the host named in the visible sentence, which the paradox paragraph above already does — it attributes the weakest-ROI framing and the −$20,000-to-+$30,000 delta to MedMoneyGuide by name. Verified rather than changed. See 9 for the decision. ↩ ↩2

  8. Endocrinologist compensation figures, experience curve, state-by-state pay, bonus. Physicians Thrive — Endocrinologist Salary (2024/2025), reporting Medscape data (https://physiciansthrive.com/physician-compensation/endocrinologist/). ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8

  9. FastRVU, Endocrinology — a $245,000 median compensation estimate, a 5,700 annual wRVU median benchmark reference, a $55/wRVU contract modeling rate, and wRVU percentiles 4,500 / 5,700 / 7,100 / 8,700. https://fastrvu.com/specialties/endocrinology Corrected 2026-08-17: every figure here was attributed to MGMA 2026 DataDive, on the dashboard, in the national-number list and in the productivity percentiles. FastRVU names MGMA only to disclaim it: "FastRVU educational product. Not produced by MGMA, AMGA, SullivanCotter, CMS, or AMA," and it describes its own numbers as "survey-based planning references, not CMS salary data." The numbers were copied accurately; the publisher was not. The MGMA name is removed from all three surfaces. Corrected 2026-08-17: the removal question is settled. Saad answered with "keep them with the host named," so the $245,000 estimate and the wRVU percentiles stay, and FastRVU is named in every visible sentence that uses one — the dashboard pay-range row, the national-number bullet and the productivity paragraph — so a reader learns what the number rests on where they read it. That was already true here before the decision and is verified rather than changed. The reasoning is this site's aggregator rule, extended one row: an aggregator's planning model displayed with its provenance is worth more than a deleted figure with nothing to replace it, and $245,000 is this page's only employed-end anchor. Naming the real host remains the point; relabelling it MGMA, as this page once did, is the opposite. Corrected 2026-08-17, a second item: the national-number bullet read the three figures as one derivation, "$245,000 median compensation, on a median 5,700 wRVU/yr at ~$55/wRVU," and 5,700 at $55 is $313,500. The productivity paragraph then multiplied the top decile the same way, and 8,700 at $55 is $478,500 against a salary spectrum this page tops out at $350,000. FastRVU publishes the three as independent planning references and never multiplies them, so the incoherence was imported by the reading rather than by the source. Both sentences now say what the rate is and what it is not for. ↩ ↩2 ↩3 ↩4 ↩5

  10. BLS OEWS; endocrinology is folded into General Internal Medicine Physicians (SOC 29-1216), mean $267,200 for May 2025 on a median of $256,560. US Bureau of Labor Statistics, Occupational Employment and Wages — May 2025, Table 1 (https://www.bls.gov/news.release/archives/ocwage_05152026.htm). Updated 2026-08-18: this figure came from the Occupational Outlook Handbook pay table, which as of 2026-08-18 still prints May 2024 wages. It now comes from the Bureau's May 2025 release, published 2026-05-15. ↩

  11. PhysEmp — Endocrinology Job Market & Salary (June 2026) — full salary spectrum $175k–$350k, market midpoint ~$275k, smaller-market pay premium, clinic-grind note. https://www.physemp.com/blog/physician-job-market-analysis-report-endocrinology ↩ ↩2 ↩3

  12. Barton Associates — Endocrinologist Salary Guide (2026) — locum ($150–$200/hr; full-time locum ~$355,200/yr; hybrid ~$361,000), rural/shortage premiums, revenue levers, bonus access. https://www.bartonassociates.com/endocrinologist-salary-guide/ ↩ ↩2 ↩3

  13. Medscape Endocrinology Compensation Report 2026 (via Nuaxia) — ~4% YoY comp rise; gender gap; bonus/outside-work context. https://www.nuaxia.com/post/medscape-endocrinology ; Medscape 2025 Compensation Report (WebMD press) (https://www.webmd.com/corporate/press/20250415/medscape2025-physician-compensation-report). ↩ ↩2

  14. GLP-1 / obesity demand statistics. Forbes Health — GLP-1 Statistics & Trends (2025/2026) (https://www.forbes.com/health/weight-loss/glp-1-statistics/). ↩ ↩2 ↩3

  15. Lifestyle, schedule control, telehealth-friendliness, career longevity, who-gravitates. PhysEmp — Endocrinology vs. Rheumatology vs. Hematology (2025) (https://www.physemp.com/blog/endocrinology-vs-rheumatology-vs-hematology-comparing-im-fellowships-on-lifestyle-pay-and-job-market); Med School Insiders — "So You Want to Be an Endocrinologist" (https://medschoolinsiders.com/medical-student/so-you-want-to-be-an-endocrinologist/). ↩ ↩2 ↩3 ↩4

  16. Endocrinology burnout ~44% (among lowest); burnout drivers bureaucracy/pay, not hours. Medscape 2024 via Becker's ASC; Medscape "Endocrinologists Are Burned Out and Unhappy" (2020) (https://www.medscape.com/viewarticle/925260). ↩ ↩2 ↩3

  17. Endocrinology burnout figures in the low-to-high 30s across cycles. Medscape "Endocrinologists Happiest of All Specialties, but Burnout Also High" (2021) (https://www.medscape.com/viewarticle/946192). ↩

  18. The content-but-underpaid paradox — ~45% feel fairly paid, ~41% would take a pay cut for balance; top out-of-work happiness. Medscape Endocrinology Compensation Report (~2023–2025) (https://www.medscape.com/viewarticle/992639); Medscape (2020–2021) (https://www.medscape.com/viewarticle/946192 ; https://www.medscape.com/viewarticle/925260). Corrected 2026-08-17: this footnote and the Fun facts bullet it supports both carried "~85% would choose again" after the Wellbeing section had already retracted that figure and stated that none is asserted. Nobody has published a would-choose-again rate by specialty since about 2019, so the clause is gone from both places and the page now says one thing. ↩ ↩2 ↩3 ↩4 ↩5

  19. Women ~70% of current endocrinology fellows/trainees; among the most female-predominant IM subspecialties. AMA, "Specialties with the biggest gender imbalances" (2024–25 GME Census / JAMA) (https://www.ama-assn.org/medical-students/preparing-residency/these-physician-specialties-have-biggest-gender-imbalances). ↩

  20. Women ~44% of practicing endocrinologists; field projected to become female-predominant. Pelley et al., JCEM, via MedCentral (data through 2015) (https://www.medcentral.com/endocrinology/endocrinology-predicted-become-female-predominant-specialty); FREIDA/AMA specialty profile (~60% female faculty) (https://freida.ama-assn.org/specialty/endocrinology-diabetes-and-metabolism-im). ↩

  21. IMG majority (~55%) of incoming class; among subspecialties with highest US-citizen-IMG share; IMGs largest first-year group since ~2013. NRMP 2026 SMS press release (https://www.nrmp.org/about/news/2026/02/nrmp-publishes-results-and-data-for-the-2026-specialties-matching-service/); JCEM 2020 (https://academic.oup.com/jcem/article/105/6/1701/5809736). ↩

  22. URiM specialty-specific percentage not located in a primary source for this pass. DEI-in-endocrinology-fellowships study exists but enrollment percentages unconfirmed: An et al., Endocrine Practice (2023) (https://www.sciencedirect.com/science/article/abs/pii/S1530891X22005997). ↩

  23. Sameera Tallapureddy, MD — KevinMD, "Endocrinologists are needed more than ever. Why are they being devalued?" (2019). https://kevinmd.com/2019/05/endocrinologists-are-needed-more-than-ever-why-are-they-being-devalued.html ↩

  24. Endocrine Society — Endocrine Clinical Workforce: Supply and Demand Projections (white paper); demand/shortage framing. https://www.endocrine.org/-/media/endosociety/files/advocacy-and-outreach/other-documents/2014-06-white-paper--endocrinology-workforce ; summary via HeyHealthy (https://www.heyhealthy.com/resources/the-growing-demand-and-critical-shortage-of-endocrinologists). ↩

  25. Sub-subspecialty focus areas; ~342 completing training in 2024; REI as separate OB/GYN path; pediatric endocrinology as distinct, lower-paid pediatrics fellowship. Life/culture research synthesis; FREIDA/AMA (2024) (https://freida.ama-assn.org/specialty/endocrinology-diabetes-and-metabolism-im); ACP — Endocrinology, Diabetes & Metabolism overview (https://www.acponline.org/about-acp/about-internal-medicine/subspecialties-of-internal-medicine/endocrinology-diabetes-and-metabolism). ↩ ↩2 ↩3

  26. ~8,000 practicing endocrinologists; 37M+ with diabetes, ~96M with prediabetes; ~300 trained/year. Endocrine Society / workforce summaries via HeyHealthy (https://www.heyhealthy.com/resources/the-growing-demand-and-critical-shortage-of-endocrinologists). ↩ ↩2

  27. Workforce shortage baseline ~1,500 adult FTE, projected widening to ~2,700 adult FTE, driven by diabetes prevalence. Vigersky et al., "The Clinical Endocrinology Workforce," J Clin Endocrinol Metab 99(9):3112 (2014) (https://academic.oup.com/jcem/article-abstract/99/9/3112/2537874). ↩

  28. KFF Health Tracking Poll, fielded April 23 – May 1, 2024: 12% of US adults say they have ever taken a GLP-1 agonist, and 6% say they are currently taking one. https://www.kff.org/health-costs/kff-health-tracking-poll-may-2024-the-publics-use-and-views-of-glp-1-drugs/. Corrected 2026-08-13: this page read the 12% as current use and glossed it as "~10 million users." 12% of US adults is closer to 30 million; the ever-used and currently-using figures are different measures and the poll publishes both. ↩

Researched with AI assistance and reviewed by hand. How this site is made